These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23970018)

  • 1. Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fey MF; Buske C;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi138-43. PubMed ID: 23970018
    [No Abstract]   [Full Text] [Related]  

  • 2. Adult acute leukemia.
    Cornell RF; Palmer J
    Dis Mon; 2012 Apr; 58(4):219-38. PubMed ID: 22449370
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization of acute myeloid leukemia.
    Döhner K; Döhner H
    Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
    [No Abstract]   [Full Text] [Related]  

  • 4. CNS relapse in acute promyeloctyic leukemia.
    Housman E; Chang P; Lane SW; Blinder R; Galinsky I; Kesari S; Ho VT; Stone RM; Mullally A
    J Clin Oncol; 2010 Aug; 28(24):e409-11. PubMed ID: 20530270
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic and cytogenetic abnormalities in leukemia].
    Nakamura F; Kurokawa M
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():103-7. PubMed ID: 23133936
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fey MF; Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v158-61. PubMed ID: 20555069
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.
    Wang ML; Bailey NG
    Arch Pathol Lab Med; 2015 Oct; 139(10):1215-23. PubMed ID: 26414465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute myeloid leukemia].
    Watanabe R
    Rinsho Ketsueki; 2009 Mar; 50(3):154-9. PubMed ID: 19352081
    [No Abstract]   [Full Text] [Related]  

  • 9. Overall survival in acute myeloid leukaemia patients with and without internal tandem duplication.
    Shahab S; Qadar Z; Nadeem M; Zahid D; Ansari S; Farzana T; Taj M; Borhany M; Ahmed N; Shamsi TS
    Asian Pac J Cancer Prev; 2015; 16(1):393. PubMed ID: 25640387
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE CLINICAL SIGNIFICANCE OF GENETIC MUTATIONS IN ACUTE MYELOID LEUKEMIA].
    Goryainova NV
    Lik Sprava; 2014 Dec; (12):10-8. PubMed ID: 26638462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype.
    Bacher U; Haferlach T; Alpermann T; Kern W; Schnittger S; Haferlach C
    Leukemia; 2013 Feb; 27(2):496-500. PubMed ID: 22858909
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
    Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
    Ann Hematol; 2016 Mar; 95(4):625-35. PubMed ID: 26692090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current therapeutic concept of acute promyelocytic leukemia].
    Lengfelder E; Hehlmann R; Büchner T
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1073-9. PubMed ID: 11602915
    [No Abstract]   [Full Text] [Related]  

  • 14. FLT3-ITD in acute promyelocytic leukemia: clinical distinct profile but still controversial prognosis.
    Molica M; Breccia M
    Leuk Res; 2015 Apr; 39(4):397-9. PubMed ID: 25666257
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic factors of acute myeloid leukemia].
    Inokuchi K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors in AML in relation to (ab)normal karyotype.
    Stone RM
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational implications of somatic genomics in acute myeloid leukaemia.
    Meyer SC; Levine RL
    Lancet Oncol; 2014 Aug; 15(9):e382-94. PubMed ID: 25079101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of extramedullary acute promyelocytic leukemia.
    Menéndez A; González A; Cabrera H; Mesa J; Martínez G; Espinoza E; Hernández P
    Eur J Haematol; 2000 Mar; 64(3):201-3. PubMed ID: 10997887
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD.
    Chien W; Sun QY; Ding LW; Mayakonda A; Takao S; Liu L; Lim SL; Tan KT; Garg M; De Sousa Maria Varela A; Xiao J; Jacob N; Behrens K; Stocking C; Lill M; Madan V; Hattori N; Gery S; Ogawa S; Wakita S; Ikezoe T; Shih LY; Alpermann T; Haferlach T; Yang H; Koeffler HP
    Leukemia; 2017 Mar; 31(3):762-766. PubMed ID: 27881871
    [No Abstract]   [Full Text] [Related]  

  • 20. Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations.
    Marceau-Renaut A; Guihard S; Castaigne S; Dombret H; Preudhomme C; Cheok M
    Am J Hematol; 2015 May; 90(5):E93-4. PubMed ID: 25611491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.